Monitor keratoconus progression after cross-linking treatment

Contemporary scleral lenses work so well that stable vision in them cannot necessarily be taken as a sign that KC progression has stopped. Determination of KC progression requires advanced imaging.

Patricia Piers, PhD, discusses a career of innovation in ophthalmology, looks to future

In a two-decade career as a researcher at Johnson & Johnson Surgical Vision, Piers has been a part of teams at the forefront of a number of innovations in IOLs. She discusses her career and the outlook for research and development in ophthalmology.

Study examines dropless cataract surgery

Investigators find a link with a postoperative prolonged steroid response.

Alcon completes acquisition of Aerie Pharmaceuticals

November 22, 2022

The deal adds pharmaceutical research and development capabilities and further expertise for future product pipeline. It also expands Alcon’s presence in the $20 billion global ophthalmic pharmaceutical category.

EP. 5: EyeCon 2022: Last chance to earn those end-of-year CME credits

November 10, 2022

This December, the Ophthalmology Times® EyeCon 2022 at the JW Marriott Marco Island Beach Resort in Florida will provide attendees with an end-of-year opportunity to meet their continuing medical education requirements. This activity has been approved for 12.50 AMA PRA Category 1 Credits™.